Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

An antibiofilm coating of 5-aryl-2-aminoimidazole covalently attached to a titanium surface.

Peeters E, Hooyberghs G, Robijns S, De Weerdt A, Kucharíková S, Tournu H, Braem A, Čeh K, Majdič G, Španič T, Pogorevc E, Claes B, Dovgan B, Girandon L, Impellizzeri F, Erdtmann M, Krona A, Vleugels J, Fröhlich M, Garcia-Forgas J, De Brucker K, Cammue BPA, Thevissen K, Van Dijck P, Vanderleyden J, Van der Eycken E, Steenackers HP.

J Biomed Mater Res B Appl Biomater. 2018 Dec 13. doi: 10.1002/jbm.b.34283. [Epub ahead of print]

PMID:
30549192
2.

A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.

Vandecasteele E, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Thevissen K, Brusselle G, Smith V.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):95-101. Epub 2018 Aug 28.

PMID:
30183593
3.

Structure-activity relationship study of the antimicrobial CRAMP-derived peptide CRAMP20-33.

Winderickx S, De Brucker K, Bird MJ, Windmolders P, Meert E, Cammue BPA, Thevissen K.

Peptides. 2018 Nov;109:33-38. doi: 10.1016/j.peptides.2018.08.013. Epub 2018 Aug 31.

PMID:
30176261
4.

From Regulated Cell Death to Adaptive Stress Strategies: Convergence and Divergence in Eukaryotic Cells.

Büttner S, Ludovico P, Thevissen K.

Oxid Med Cell Longev. 2018 Jun 24;2018:2480462. doi: 10.1155/2018/2480462. eCollection 2018. No abstract available.

5.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

6.

Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.

Yeaman MR, Büttner S, Thevissen K.

Oxid Med Cell Longev. 2018 Apr 26;2018:5473817. doi: 10.1155/2018/5473817. eCollection 2018. Review.

7.

Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.

Gerits E, Spincemaille P, De Cremer K, De Brucker K, Beullens S, Thevissen K, Cammue BPA, Vandamme K, Fauvart M, Verstraeten N, Michiels J.

Clin Exp Dent Res. 2017 Apr 7;3(2):69-76. doi: 10.1002/cre2.65. eCollection 2017 Apr.

8.

Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts.

Varkas G, Vastesaeger N, Cypers H, Colman R, Renson T, Praet LV, Carron P, Raeman F, Devinck M, Gyselbrecht L, Corluy L, Piette Y, Lenaerts J, Thevissen K, Vanneuville B, Bosch FVD, Elewaut D.

Arthritis Rheumatol. 2018 Oct;70(10):1588-1596. doi: 10.1002/art.40551.

PMID:
29740978
9.

In vitro methods for the evaluation of antimicrobial surface designs.

Sjollema J, Zaat SAJ, Fontaine V, Ramstedt M, Luginbuehl R, Thevissen K, Li J, van der Mei HC, Busscher HJ.

Acta Biomater. 2018 Apr 1;70:12-24. doi: 10.1016/j.actbio.2018.02.001. Epub 2018 Feb 10. Review.

PMID:
29432983
10.

Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal.

Cutolo M, Melsens K, Wijnant S, Ingegnoli F, Thevissen K, De Keyser F, Decuman S, Müller-Ladner U, Piette Y, Riccieri V, Ughi N, Vandecasteele E, Vanhaecke A, Smith V.

Autoimmun Rev. 2018 Apr;17(4):344-352. doi: 10.1016/j.autrev.2017.11.025. Epub 2018 Feb 8. Review.

PMID:
29427827
11.

Guidelines and recommendations on yeast cell death nomenclature.

Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, Cavalieri D, Chang M, Cooper KF, Côrte-Real M, Costa V, Cullin C, Dawes I, Dengjel J, Dickman MB, Eisenberg T, Fahrenkrog B, Fasel N, Fröhlich KU, Gargouri A, Giannattasio S, Goffrini P, Gourlay CW, Grant CM, Greenwood MT, Guaragnella N, Heger T, Heinisch J, Herker E, Herrmann JM, Hofer S, Jiménez-Ruiz A, Jungwirth H, Kainz K, Kontoyiannis DP, Ludovico P, Manon S, Martegani E, Mazzoni C, Megeney LA, Meisinger C, Nielsen J, Nyström T, Osiewacz HD, Outeiro TF, Park HO, Pendl T, Petranovic D, Picot S, Polčic P, Powers T, Ramsdale M, Rinnerthaler M, Rockenfeller P, Ruckenstuhl C, Schaffrath R, Segovia M, Severin FF, Sharon A, Sigrist SJ, Sommer-Ruck C, Sousa MJ, Thevelein JM, Thevissen K, Titorenko V, Toledano MB, Tuite M, Vögtle FN, Westermann B, Winderickx J, Wissing S, Wölfl S, Zhang ZJ, Zhao RY, Zhou B, Galluzzi L, Kroemer G, Madeo F.

Microb Cell. 2018 Jan 1;5(1):4-31. doi: 10.15698/mic2018.01.607. Review.

12.

The Antifungal Plant Defensin HsAFP1 Is a Phosphatidic Acid-Interacting Peptide Inducing Membrane Permeabilization.

Cools TL, Vriens K, Struyfs C, Verbandt S, Ramada MHS, Brand GD, Bloch C Jr, Koch B, Traven A, Drijfhout JW, Demuyser L, Kucharíková S, Van Dijck P, Spasic D, Lammertyn J, Cammue BPA, Thevissen K.

Front Microbiol. 2017 Nov 21;8:2295. doi: 10.3389/fmicb.2017.02295. eCollection 2017.

13.

Capillaroscopy in pregnancy.

Thevissen K, Gyselaers W.

Expert Rev Med Devices. 2017 Dec;14(12):961-967. doi: 10.1080/17434440.2017.1409113. Epub 2017 Nov 27. Review.

PMID:
29161915
14.

Increasing the Fungicidal Action of Amphotericin B by Inhibiting the Nitric Oxide-Dependent Tolerance Pathway.

Vriens K, Kumar PT, Struyfs C, Cools TL, Spincemaille P, Kokalj T, Sampaio-Marques B, Ludovico P, Lammertyn J, Cammue BPA, Thevissen K.

Oxid Med Cell Longev. 2017;2017:4064628. doi: 10.1155/2017/4064628. Epub 2017 Oct 10.

15.

A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms.

Cools TL, Struyfs C, Drijfhout JW, Kucharíková S, Lobo Romero C, Van Dijck P, Ramada MHS, Bloch C Jr, Cammue BPA, Thevissen K.

Front Microbiol. 2017 Oct 20;8:2051. doi: 10.3389/fmicb.2017.02051. eCollection 2017.

16.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
17.

Fungal Glucosylceramide-Specific Camelid Single Domain Antibodies Are Characterized by Broad Spectrum Antifungal Activity.

De Coninck B, Verheesen P, Vos CM, Van Daele I, De Bolle MF, Vieira JV, Peferoen M, Cammue BPA, Thevissen K.

Front Microbiol. 2017 Jun 14;8:1059. doi: 10.3389/fmicb.2017.01059. eCollection 2017.

18.

Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.

Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, Decuman S, Bonroy C, Piette Y, De Keyser F, Brusselle G, Smith V.

Eur Respir J. 2017 May 11;49(5). pii: 1602275. doi: 10.1183/13993003.02275-2016. Print 2017 May.

19.

Antifungal plant defensins: increased insight in their mode of action as a basis for their use to combat fungal infections.

Cools TL, Struyfs C, Cammue BP, Thevissen K.

Future Microbiol. 2017 Apr;12:441-454. doi: 10.2217/fmb-2016-0181. Epub 2017 Mar 24.

PMID:
28339295
20.

Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice.

Verbeek J, Spincemaille P, Vanhorebeek I, Van den Berghe G, Vander Elst I, Windmolders P, van Pelt J, van der Merwe S, Bedossa P, Nevens F, Cammue B, Thevissen K, Cassiman D.

Lipids Health Dis. 2017 Feb 23;16(1):46. doi: 10.1186/s12944-017-0432-7.

21.

Six-minute walk test in or out in evaluation of systemic sclerosis patients?

Vandecasteele E, Thevissen K, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Brusselle G, Smith V.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):122-129. Epub 2017 Feb 15.

PMID:
28229829
22.

Alternating Current Electrophoretic Deposition for the Immobilization of Antimicrobial Agents on Titanium Implant Surfaces.

Braem A, De Brucker K, Delattin N, Killian MS, Roeffaers MB, Yoshioka T, Hayakawa S, Schmuki P, Cammue BP, Virtanen S, Thevissen K, Neirinck B.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8533-8546. doi: 10.1021/acsami.6b16433. Epub 2017 Mar 6.

PMID:
28211996
23.

In vitro activity of the antiasthmatic drug zafirlukast against the oral pathogens Porphyromonas gingivalis and Streptococcus mutans.

Gerits E, Van der Massen I, Vandamme K, De Cremer K, De Brucker K, Thevissen K, Cammue BPA, Beullens S, Fauvart M, Verstraeten N, Michiels J, Roberts M.

FEMS Microbiol Lett. 2017 Jan 1;364(2). doi: 10.1093/femsle/fnx005.

PMID:
28087617
24.

Controlled release of chlorhexidine from a mesoporous silica-containing macroporous titanium dental implant prevents microbial biofilm formation.

De Cremer K, Braem A, Gerits E, De Brucker K, Vandamme K, Martens JA, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Eur Cell Mater. 2017 Jan 11;33:13-27. doi: 10.22203/eCM.v033a02.

25.

Repurposing Toremifene for Treatment of Oral Bacterial Infections.

Gerits E, Defraine V, Vandamme K, De Cremer K, De Brucker K, Thevissen K, Cammue BP, Beullens S, Fauvart M, Verstraeten N, Michiels J.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01846-16. doi: 10.1128/AAC.01846-16. Print 2017 Mar.

26.

An induction or flare of arthritis and/or sacroiliitis by vedolizumab in inflammatory bowel disease: a case series.

Varkas G, Thevissen K, De Brabanter G, Van Praet L, Czul-Gurdian F, Cypers H, De Kock J, Carron P, De Vos M, Hindryckx P, Arts J, Vanneuville I, Schoenaers P, Claerhout B, Abreu M, Van den Bosch F, Elewaut D.

Ann Rheum Dis. 2017 May;76(5):878-881. doi: 10.1136/annrheumdis-2016-210233. Epub 2016 Nov 29.

PMID:
27899374
27.

Expanding the pharmacological profile of κ-hefutoxin 1 and analogues: A focus on the inhibitory effect on the oncogenic channel Kv10.1.

Moreels L, Peigneur S, Yamaguchi Y, Vriens K, Waelkens E, Zhu S, Thevissen K, Cammue BPA, Sato K, Tytgat J.

Peptides. 2017 Dec;98:43-50. doi: 10.1016/j.peptides.2016.08.008. Epub 2016 Aug 28.

PMID:
27578329
28.

The antifungal plant defensin AtPDF2.3 from Arabidopsis thaliana blocks potassium channels.

Vriens K, Peigneur S, De Coninck B, Tytgat J, Cammue BP, Thevissen K.

Sci Rep. 2016 Aug 30;6:32121. doi: 10.1038/srep32121.

29.

Modulation of the Substitution Pattern of 5-Aryl-2-Aminoimidazoles Allows Fine-Tuning of Their Antibiofilm Activity Spectrum and Toxicity.

Peeters E, Hooyberghs G, Robijns S, Waldrant K, De Weerdt A, Delattin N, Liebens V, Kucharíková S, Tournu H, Verstraeten N, Dovgan B, Girandon L, Fröhlich M, De Brucker K, Van Dijck P, Michiels J, Cammue BP, Thevissen K, Vanderleyden J, Van der Eycken E, Steenackers HP.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6483-6497. doi: 10.1128/AAC.00035-16. Print 2016 Nov.

30.

Identification of survival-promoting OSIP108 peptide variants and their internalization in human cells.

Verbandt S, Henriques ST, Spincemaille P, Harvey PJ, Chandhok G, Sauer V, De Coninck B, Cassiman D, Craik DJ, Cammue BPA, De Cremer K, Thevissen K.

Mech Ageing Dev. 2017 Jan;161(Pt B):247-254. doi: 10.1016/j.mad.2016.07.013. Epub 2016 Aug 1.

PMID:
27491841
31.

How promising are combinatorial drug strategies in combating Candida albicans biofilms?

Thevissen K.

Future Med Chem. 2016 Aug;8(12):1383-5. doi: 10.4155/fmc-2016-0127. Epub 2016 Jul 27. No abstract available.

PMID:
27463947
32.

Antimicrobial Peptides as a Strategy to Combat Fungal Biofilms.

Delattin N, Brucker K, Cremer K, Cammue BP, Thevissen K.

Curr Top Med Chem. 2017;17(5):604-612. Review.

PMID:
27411323
33.

Yeast as a model for the identification of novel survival-promoting compounds applicable to treat degenerative diseases.

Verbandt S, Cammue BPA, Thevissen K.

Mech Ageing Dev. 2017 Jan;161(Pt B):306-316. doi: 10.1016/j.mad.2016.06.003. Epub 2016 Jun 7. Review.

PMID:
27287065
34.

Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilms.

De Cremer K, De Brucker K, Staes I, Peeters A, Van den Driessche F, Coenye T, Cammue BP, Thevissen K.

Sci Rep. 2016 Jun 7;6:27463. doi: 10.1038/srep27463.

35.

Non-disulfide-bridged peptides from Tityus serrulatus venom: Evidence for proline-free ACE-inhibitors.

Pucca MB, Cerni FA, Pinheiro-Junior EL, Zoccal KF, Bordon KCF, Amorim FG, Peigneur S, Vriens K, Thevissen K, Cammue BPA, Júnior RBM, Arruda E, Faccioli LH, Tytgat J, Arantes EC.

Peptides. 2016 Aug;82:44-51. doi: 10.1016/j.peptides.2016.05.008. Epub 2016 May 21.

PMID:
27221550
36.

Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa.

Gerits E, Blommaert E, Lippell A, O'Neill AJ, Weytjens B, De Maeyer D, Fierro AC, Marchal K, Marchand A, Chaltin P, Spincemaille P, De Brucker K, Thevissen K, Cammue BP, Swings T, Liebens V, Fauvart M, Verstraeten N, Michiels J.

PLoS One. 2016 May 11;11(5):e0155139. doi: 10.1371/journal.pone.0155139. eCollection 2016.

37.

Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Smith V, Thevissen K, Trombetta AC, Pizzorni C, Ruaro B, Piette Y, Paolino S, De Keyser F, Sulli A, Melsens K, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review.

PMID:
27086648
38.

Antibacterial activity of a new broad-spectrum antibiotic covalently bound to titanium surfaces.

Gerits E, Kucharíková S, Van Dijck P, Erdtmann M, Krona A, Lövenklev M, Fröhlich M, Dovgan B, Impellizzeri F, Braem A, Vleugels J, Robijns SC, Steenackers HP, Vanderleyden J, De Brucker K, Thevissen K, Cammue BP, Fauvart M, Verstraeten N, Michiels J.

J Orthop Res. 2016 Dec;34(12):2191-2198. doi: 10.1002/jor.23238. Epub 2016 Apr 6.

39.

Covalent immobilization of antimicrobial agents on titanium prevents Staphylococcus aureus and Candida albicans colonization and biofilm formation.

Kucharíková S, Gerits E, De Brucker K, Braem A, Ceh K, Majdič G, Španič T, Pogorevc E, Verstraeten N, Tournu H, Delattin N, Impellizzeri F, Erdtmann M, Krona A, Lövenklev M, Knezevic M, Fröhlich M, Vleugels J, Fauvart M, de Silva WJ, Vandamme K, Garcia-Forgas J, Cammue BP, Michiels J, Van Dijck P, Thevissen K.

J Antimicrob Chemother. 2016 Apr;71(4):936-45. doi: 10.1093/jac/dkv437. Epub 2015 Dec 24.

PMID:
26702917
40.

The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.

Vriens K, Cools TL, Harvey PJ, Craik DJ, Braem A, Vleugels J, De Coninck B, Cammue BP, Thevissen K.

Peptides. 2016 Jan;75:71-9. doi: 10.1016/j.peptides.2015.11.001. Epub 2015 Nov 28.

PMID:
26592804
41.

Protocol for Determination of the Persister Subpopulation in Candida Albicans Biofilms.

De Brucker K, De Cremer K, Cammue BP, Thevissen K.

Methods Mol Biol. 2016;1333:67-72. doi: 10.1007/978-1-4939-2854-5_6.

PMID:
26468100
42.

Synergistic Activity of the Plant Defensin HsAFP1 and Caspofungin against Candida albicans Biofilms and Planktonic Cultures.

Vriens K, Cools TL, Harvey PJ, Craik DJ, Spincemaille P, Cassiman D, Braem A, Vleugels J, Nibbering PH, Drijfhout JW, De Coninck B, Cammue BP, Thevissen K.

PLoS One. 2015 Aug 6;10(8):e0132701. doi: 10.1371/journal.pone.0132701. eCollection 2015.

43.

Combinatorial drug approaches to tackle Candida albicans biofilms.

De Cremer K, Staes I, Delattin N, Cammue BP, Thevissen K, De Brucker K.

Expert Rev Anti Infect Ther. 2015 Aug;13(8):973-84. doi: 10.1586/14787210.2015.1056162. Epub 2015 Jun 12. Review.

PMID:
26070384
44.

Fungal β-1,3-glucan increases ofloxacin tolerance of Escherichia coli in a polymicrobial E. coli/Candida albicans biofilm.

De Brucker K, Tan Y, Vints K, De Cremer K, Braem A, Verstraeten N, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2015;59(6):3052-8. doi: 10.1128/AAC.04650-14. Epub 2015 Mar 9.

45.

Digital microfluidics for time-resolved cytotoxicity studies on single non-adherent yeast cells.

Kumar PT, Vriens K, Cornaglia M, Gijs M, Kokalj T, Thevissen K, Geeraerd A, Cammue BP, Puers R, Lammertyn J.

Lab Chip. 2015 Apr 21;15(8):1852-60. doi: 10.1039/c4lc01469c.

PMID:
25710603
46.

Novel anti-infective implant substrates: controlled release of antibiofilm compounds from mesoporous silica-containing macroporous titanium.

Braem A, De Cremer K, Delattin N, De Brucker K, Neirinck B, Vandamme K, Martens JA, Michiels J, Vleugels J, Cammue BP, Thevissen K.

Colloids Surf B Biointerfaces. 2015 Feb 1;126:481-8. doi: 10.1016/j.colsurfb.2014.12.054. Epub 2015 Jan 7.

PMID:
25601097
47.

2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.

Bardiot D, Thevissen K, De Brucker K, Peeters A, Cos P, Taborda CP, McNaughton M, Maes L, Chaltin P, Cammue BP, Marchand A.

J Med Chem. 2015 Feb 12;58(3):1502-12. doi: 10.1021/jm501814x. Epub 2015 Jan 28.

PMID:
25585716
48.

Identification and characterization of an anti-pseudomonal dichlorocarbazol derivative displaying anti-biofilm activity.

Liebens V, Gerits E, Knapen WJ, Swings T, Beullens S, Steenackers HP, Robijns S, Lippell A, O'Neill AJ, Veber M, Fröhlich M, Krona A, Lövenklev M, Corbau R, Marchand A, Chaltin P, De Brucker K, Thevissen K, Cammue BP, Fauvart M, Verstraeten N, Michiels J.

Bioorg Med Chem Lett. 2014 Dec 1;24(23):5404-8.

PMID:
25453797
49.

Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.

De Cremer K, Lanckacker E, Cools TL, Bax M, De Brucker K, Cos P, Cammue BP, Thevissen K.

Antimicrob Agents Chemother. 2015 Jan;59(1):421-6. doi: 10.1128/AAC.04229-14. Epub 2014 Nov 3.

50.

Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.

Spincemaille P, Chandhok G, Zibert A, Schmidt H, Verbeek J, Chaltin P, Cammue BP, Cassiman D, Thevissen K.

Microb Cell. 2014 Oct 24;1(11):352-364. doi: 10.15698/mic2014.11.175.

Supplemental Content

Loading ...
Support Center